These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7986233)

  • 1. Suggested guidelines for monitoring liver toxicity in rheumatoid arthritis patients treated with methotrexate: comment on the article by Kremer et al.
    Fries JF; Ramey DR; Singh G
    Arthritis Rheum; 1994 Dec; 37(12):1829-30. PubMed ID: 7986233
    [No Abstract]   [Full Text] [Related]  

  • 2. Creating a care-effective cost-effective strategy for methotrexate liver toxicity monitoring in rheumatoid arthritis: comment on the article by Kremer et al.
    Newman ED; Harrington TM; Perruquet JL; Davis DE; Torretti D
    Arthritis Rheum; 1995 Feb; 38(2):297-8. PubMed ID: 7848325
    [No Abstract]   [Full Text] [Related]  

  • 3. Monitoring for methotrexate hepatotoxicity in patients with rheumatoid arthritis: another hepatologist's perspective.
    Lewis JH
    J Rheumatol; 1997 Aug; 24(8):1459-60. PubMed ID: 9263133
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring methotrexate hepatic toxicity in rheumatoid arthritis: is it time to update the guidelines?
    Yazici Y; Erkan D; Paget SA
    J Rheumatol; 2002 Aug; 29(8):1586-9. PubMed ID: 12180713
    [No Abstract]   [Full Text] [Related]  

  • 5. Not yet time to change the guidelines for monitoring methotrexate liver toxicity: they have served us well.
    Kremer JM
    J Rheumatol; 2002 Aug; 29(8):1590-2. PubMed ID: 12180714
    [No Abstract]   [Full Text] [Related]  

  • 6. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
    Sante; 2001; 11(3):195-200. PubMed ID: 11641084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: J.M. Kremer--editorial.
    Levin DM
    Am J Gastroenterol; 1997 Aug; 92(8):1402-3. PubMed ID: 9260830
    [No Abstract]   [Full Text] [Related]  

  • 8. Comment on: Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
    Lynch M; Kirby B
    Rheumatology (Oxford); 2010 Jan; 49(1):196-7; author reply 197-8. PubMed ID: 19858119
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring guidelines for methotrexate-treated rheumatoid arthritis patients: comment on the article by Yazici et al.
    Alarcón GS; Kremer J; Weinblatt M
    Arthritis Rheum; 2004 Aug; 50(8):2710; author reply 2710-1. PubMed ID: 15334490
    [No Abstract]   [Full Text] [Related]  

  • 10. Folic acid treatment in methotrexate-treated rheumatoid arthritis patients: comment on the article by Furst and Kremer.
    Arthritis Rheum; 1989 Jan; 32(1):113-4. PubMed ID: 2912459
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring patients taking methotrexate for hepatotoxicity. Does the standard of care match published guidelines?
    Petrazzuoli M; Rothe MJ; Grin-Jorgensen C; Ramsey WH; Grant-Kels JM
    J Am Acad Dermatol; 1994 Dec; 31(6):969-77. PubMed ID: 7962779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate and liver toxicity: role of surveillance liver biopsy. Conflict between guidelines for rheumatologists and dermatologists.
    Hassan W
    Ann Rheum Dis; 1996 May; 55(5):273-5. PubMed ID: 8660097
    [No Abstract]   [Full Text] [Related]  

  • 13. Guidelines for routine liver biopsy during methotrexate treatment.
    Cash JM; Wilke WS
    Cleve Clin J Med; 1994; 61(4):317-8. PubMed ID: 7923752
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver biopsies in patients with rheumatoid arthritis receiving methotrexate: where are we going?
    Kremer JM
    J Rheumatol; 1992 Feb; 19(2):189-91. PubMed ID: 1629814
    [No Abstract]   [Full Text] [Related]  

  • 15. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology.
    Kremer JM; Alarcón GS; Lightfoot RW; Willkens RF; Furst DE; Williams HJ; Dent PB; Weinblatt ME
    Arthritis Rheum; 1994 Mar; 37(3):316-28. PubMed ID: 8129787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with methotrexate-associated pneumonitis in northeastern England: comment on the article by Kremer et al.
    Bartram SA
    Arthritis Rheum; 1998 Jul; 41(7):1327-8. PubMed ID: 9663497
    [No Abstract]   [Full Text] [Related]  

  • 17. Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients.
    Erickson AR; Reddy V; Vogelgesang SA; West SG
    Arthritis Rheum; 1995 Aug; 38(8):1115-9. PubMed ID: 7639808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment with every-other-week methotrexate in rheumatoid arthritis patients with sustained disease improvement: comment on the article by Kremer et al.
    Roth SH
    Arthritis Rheum; 1995 Dec; 38(12):1865-6. PubMed ID: 8849365
    [No Abstract]   [Full Text] [Related]  

  • 19. Methotrexate therapy, rheumatoid arthritis, and life-threatening liver complications: should we be monitoring more closely?
    Tugnet N; Cooper SC; Douglas KM
    Scand J Rheumatol; 2012 Mar; 41(2):163-4. PubMed ID: 22420415
    [No Abstract]   [Full Text] [Related]  

  • 20. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.